Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

The identification of challenges in tissue collection for biomarker studies: the Q-CROC-03 neoadjuvant breast cancer translational trial experience.

Aguilar-Mahecha A, Lafleur J, Pelmus M, Seguin C, Lan C, Discepola F, Kovacina B, Christodoulopoulos R, Salvucci O, Mihalcioiu C, Roy JA, Robidoux A, Marcus EA, Batist G, Basik M.

Mod Pathol. 2017 Nov;30(11):1567-1576. doi: 10.1038/modpathol.2017.82. Epub 2017 Jul 28.

PMID:
28752846
2.

Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.

Kwak H, Salvucci O, Weigert R, Martinez-Torrecuadrada JL, Henkemeyer M, Poulos MG, Butler JM, Tosato G.

J Clin Invest. 2016 Dec 1;126(12):4554-4568. doi: 10.1172/JCI87848. Epub 2016 Nov 7.

3.

Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling.

Espígol-Frigolé G, Planas-Rigol E, Ohnuki H, Salvucci O, Kwak H, Ravichandran S, Luke B, Cid MC, Tosato G.

Sci Signal. 2016 Mar 15;9(419):ra28. doi: 10.1126/scisignal.aad2357.

PMID:
26980441
4.

EphrinB2 controls vessel pruning through STAT1-JNK3 signalling.

Salvucci O, Ohnuki H, Maric D, Hou X, Li X, Yoon SO, Segarra M, Eberhart CG, Acker-Palmer A, Tosato G.

Nat Commun. 2015 Mar 26;6:6576. doi: 10.1038/ncomms7576.

5.

Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression.

Ohnuki H, Jiang K, Wang D, Salvucci O, Kwak H, Sánchez-Martín D, Maric D, Tosato G.

Cancer Res. 2014 Apr 1;74(7):2038-49. doi: 10.1158/0008-5472.CAN-13-3118. Epub 2014 Feb 11.

6.

Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.

Falivelli G, Lisabeth EM, Rubio de la Torre E, Perez-Tenorio G, Tosato G, Salvucci O, Pasquale EB.

PLoS One. 2013 Nov 29;8(11):e81445. doi: 10.1371/journal.pone.0081445. eCollection 2013.

7.

Semaphorin 6A regulates angiogenesis by modulating VEGF signaling.

Segarra M, Ohnuki H, Maric D, Salvucci O, Hou X, Kumar A, Li X, Tosato G.

Blood. 2012 Nov 8;120(19):4104-15. doi: 10.1182/blood-2012-02-410076. Epub 2012 Sep 24.

8.

Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.

Salvucci O, Tosato G.

Adv Cancer Res. 2012;114:21-57. doi: 10.1016/B978-0-12-386503-8.00002-8. Review.

9.

MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1.

Salvucci O, Jiang K, Gasperini P, Maric D, Zhu J, Sakakibara S, Espigol-Frigole G, Wang S, Tosato G.

Haematologica. 2012 Jun;97(6):818-26. doi: 10.3324/haematol.2011.056945. Epub 2012 Jan 22.

10.

Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling.

Gasperini P, Espigol-Frigole G, McCormick PJ, Salvucci O, Maric D, Uldrick TS, Polizzotto MN, Yarchoan R, Tosato G.

Cancer Res. 2012 Mar 1;72(5):1157-69. doi: 10.1158/0008-5472.CAN-11-3067. Epub 2012 Jan 11.

11.

PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.

Noberini R, Mitra S, Salvucci O, Valencia F, Duggineni S, Prigozhina N, Wei K, Tosato G, Huang Z, Pasquale EB.

PLoS One. 2011;6(12):e28611. doi: 10.1371/journal.pone.0028611. Epub 2011 Dec 14.

12.

Adult human circulating CD34⁻Lin⁻CD45⁻CD133⁻ cells can differentiate into hematopoietic and endothelial cells.

Ciraci E, Della Bella S, Salvucci O, Rofani C, Segarra M, Bason C, Molinari A, Maric D, Tosato G, Berardi AC.

Blood. 2011 Aug 25;118(8):2105-15. doi: 10.1182/blood-2010-10-316596. Epub 2011 Jun 29.

13.

CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model.

Hassan S, Buchanan M, Jahan K, Aguilar-Mahecha A, Gaboury L, Muller WJ, Alsawafi Y, Mourskaia AA, Siegel PM, Salvucci O, Basik M.

Int J Cancer. 2011 Jul 1;129(1):225-32. doi: 10.1002/ijc.25665. Epub 2010 Nov 12.

14.

Cytosolic phospholipase A2{alpha} and cancer: a role in tumor angiogenesis.

Tosato G, Segarra M, Salvucci O.

J Natl Cancer Inst. 2010 Sep 22;102(18):1377-9. doi: 10.1093/jnci/djq324. Epub 2010 Aug 20. No abstract available.

PMID:
20729476
15.

The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1.

de la Luz Sierra M, Sakakibara S, Gasperini P, Salvucci O, Jiang K, McCormick PJ, Segarra M, Stone J, Maric D, Zhu J, Qian X, Lowy DR, Tosato G.

Blood. 2010 May 13;115(19):3970-9. doi: 10.1182/blood-2009-10-246967. Epub 2010 Mar 4.

16.

The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer.

Hassan S, Ferrario C, Saragovi U, Quenneville L, Gaboury L, Baccarelli A, Salvucci O, Basik M.

Am J Pathol. 2009 Jul;175(1):66-73. doi: 10.2353/ajpath.2009.080948. Epub 2009 Jun 4.

17.

EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.

Salvucci O, Maric D, Economopoulou M, Sakakibara S, Merlin S, Follenzi A, Tosato G.

Blood. 2009 Aug 20;114(8):1707-16. doi: 10.1182/blood-2008-12-192294. Epub 2009 May 1.

18.

Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.

Berardi AC, Marsilio S, Rofani C, Salvucci O, Altavista P, Perla FM, Diomedi-Camassei F, Uccini S, Kokai G, Landuzzi L, McDowell HP, Dominici C.

Anticancer Res. 2008 Mar-Apr;28(2A):763-9.

19.

Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.

Hassan S, Baccarelli A, Salvucci O, Basik M.

Clin Cancer Res. 2008 Jan 15;14(2):446-54. doi: 10.1158/1078-0432.CCR-07-1189.

20.

EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling.

Salvucci O, de la Luz Sierra M, Martina JA, McCormick PJ, Tosato G.

Blood. 2006 Nov 1;108(9):2914-22. Epub 2006 Jul 13.

21.

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

Salvucci O, Bouchard A, Baccarelli A, Deschênes J, Sauter G, Simon R, Bianchi R, Basik M.

Breast Cancer Res Treat. 2006 Jun;97(3):275-83. Epub 2005 Dec 13.

PMID:
16344916
22.

Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma.

Salvucci O, Basik M, Yao L, Bianchi R, Tosato G.

J Leukoc Biol. 2004 Jul;76(1):217-26. Epub 2004 Apr 1.

PMID:
15075355
23.

Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.

De La Luz Sierra M, Yang F, Narazaki M, Salvucci O, Davis D, Yarchoan R, Zhang HH, Fales H, Tosato G.

Blood. 2004 Apr 1;103(7):2452-9. Epub 2003 Oct 2.

24.

Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo.

Villalba S, Salvucci O, Aoki Y, De La Luz Sierra M, Gupta G, Davis D, Wyvill K, Little R, Yarchoan R, Tosato G.

J Leukoc Biol. 2003 Nov;74(5):880-8. Epub 2003 Jul 22.

PMID:
12960279
25.

Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis.

Yao L, Salvucci O, Cardones AR, Hwang ST, Aoki Y, De La Luz Sierra M, Sajewicz A, Pittaluga S, Yarchoan R, Tosato G.

Blood. 2003 Dec 1;102(12):3900-5. Epub 2003 Aug 7.

26.

Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.

Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G.

Blood. 2002 Apr 15;99(8):2703-11.

27.

Antiapoptotic role of endogenous nitric oxide in human melanoma cells.

Salvucci O, Carsana M, Bersani I, Tragni G, Anichini A.

Cancer Res. 2001 Jan 1;61(1):318-26.

28.

Dysregulation of interleukin-2 receptor beta and interleukin-2 receptor gamma expression during HIV infection.

David D, Bani L, Moreau JL, Treilhou MP, Demaison C, Sun K, Février M, Salvucci O, Cayota A, Nakarai T, Chouaïb S, de Montalembert M, Joussemet M, Sugamura K, Ritz J, Dupont B, Pialoux G, Thèze J.

Eur Cytokine Netw. 1998 Sep;9(3 Suppl):97-101. Review. No abstract available.

PMID:
9831196
30.

Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets.

David D, Bani L, Moreau JL, Demaison C, Sun K, Salvucci O, Nakarai T, de Montalembert M, Chouaïb S, Joussemet M, Ritz J, Thèze J.

Blood. 1998 Jan 1;91(1):165-72.

31.

IL-15 enhances immune functions during HIV infection.

Chehimi J, Marshall JD, Salvucci O, Frank I, Chehimi S, Kawecki S, Bacheller D, Rifat S, Chouaib S.

J Immunol. 1997 Jun 15;158(12):5978-87.

PMID:
9190952
32.

Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.

Salvucci O, Mami-Chouaib F, Moreau JL, Thèze J, Chehimi J, Chouaib S.

Eur J Immunol. 1996 Nov;26(11):2736-41.

PMID:
8921963
33.

DNA-protein cell content of lymphokine activated killer (LAK) and target cells in coculture.

Nano R, Barni S, Capelli E, Prosperi E, Lavezzi L, Salvucci O.

Anticancer Res. 1995 May-Jun;15(3):751-4.

PMID:
7645953

Supplemental Content

Loading ...
Support Center